Immuneering IMRX
NASDAQ IMRX
$3.84 -0.01 (-0.39%)
As of: Nov 11, 2026 · 3:51 PM EST

Immuneering (IMRX) Change in Accrued Expenses (2020 - 2026)

Updated

Immuneering's Change in Accrued Expenses came in at $3.4 million for Q3 2026, up 43.8% from $2.37 million a year earlier and up 230.2% from the prior quarter.

Analysis

Immuneering (IMRX) Change in Accrued Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Immuneering reported Change in Accrued Expenses of $646,272, down 71.8% year-over-year; for FY2025, it came in at $2.9 million.

  • Change in Accrued Expenses carries a five-year compound annual growth rate of 42.8% (FY2020 to FY2025).
  • Going back by year, Change in Accrued Expenses was -$200,831 in FY2024, $721,989 in FY2023 (+52.1%), $474,568 in FY2022 (-85.4%) and $3.24 million in FY2021 (+563.3%).
  • The Q3 2026 figure represents the highest quarterly Change in Accrued Expenses in data going back to Q3 2020.
  • Year-over-year, Change in Accrued Expenses increased in three of the last six quarters, with growth averaging 47.0%.
  • The fastest year-over-year change in Change in Accrued Expenses over five years came in Q3 2025 (growth of 183.2%), and the weakest in Q2 2023 (a decline of 96.2%).
  • Business Quant data shows IMRX's Change in Accrued Expenses at $1.03 million (Q2 2026), -$4.78 million (Q1 2026) and $990,501 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immuneering 249.34 Mn -375.49 Mn - 3.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.40 Mn
Jun 30, 2026 1.03 Mn
Mar 31, 2026 -4.78 Mn
Dec 31, 2025 990,501.00
Sep 30, 2025 2.37 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 -1.61 Mn
Dec 31, 2024 380,304.00
Sep 30, 2024 835,677.00
Jun 30, 2024 1.35 Mn
Mar 31, 2024 -2.76 Mn
Dec 31, 2023 1.95 Mn
Sep 30, 2023 849,878.00
Jun 30, 2023 19,269.00
Mar 31, 2023 -2.09 Mn
Dec 31, 2022 89,032.00
Sep 30, 2022 2.11 Mn
Jun 30, 2022 507,883.00
Mar 31, 2022 -2.24 Mn
Dec 31, 2021 551,080.00
API Access

Immuneering Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEY